{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T12:11:22Z","timestamp":1655813482627},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.2169\/internalmedicine.5475-20","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:11:39Z","timestamp":1609452699000},"page":"123-130","source":"Crossref","is-referenced-by-count":3,"title":["Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid"],"prefix":"10.2169","volume":"60","author":[{"given":"Masahiro","family":"Shinoda","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Kamachi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Yoshimatsu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Boku","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatomo","family":"Hirouchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Shinada","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Shinkai","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. [cited 2020 Aug 1]. Available from: https:\/\/covid19.who.int"},{"key":"2","unstructured":"2. Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. Forthcoming."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Oestereich L, L\u00fcdtke A, Wurr S, Rieger T, Mu\u00f1oz-Fontela C, G\u00fcnther S. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res 105: 17-21, 2014.","DOI":"10.1016\/j.antiviral.2014.02.014"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gowen BB, Wong MH, Jung KH, et al. <i>In vitro<\/i> and <i>in vivo<\/i> activities of T-705 against arenavirus and bunyavirus infections. Antimicrob Agents Chemother 51: 3168-3176, 2007.","DOI":"10.1128\/AAC.00356-07"},{"key":"5","unstructured":"5. Cai Q, Yang M, Liu D, et al. Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering. Forthcoming."},{"key":"6","unstructured":"6. Horby P, Lim WS, Emberson JR, et al.; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with covid-19 - preliminary report. N Engl J Med. Forthcoming."},{"key":"7","unstructured":"7. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. Forthcoming."},{"key":"8","unstructured":"8. Kowalewski M, Fina D, S\u0142omka A, et al. COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review. Crit Care 24: 205, 2020."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323: 1061-1069, 2020.","DOI":"10.1001\/jama.2020.1585"},{"key":"10","unstructured":"10. The Japanese Society of Intensive Care Medicine, Japanese Society of Respiratory Care Medicine, and the Japanese Respiratory Society. Clinical practice guideline for the management of acute respiratory distress syndrome (ARDS) 2016 (in Japanese)."},{"key":"11","unstructured":"11. Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. Forthcoming."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Merrill JT, Erkan D, Winakur J, James JA. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol 30: 1-9, 2020.","DOI":"10.1038\/s41584-020-0474-5"},{"key":"13","unstructured":"13. The Japanese Association for Infectious Diseases [Internet]. [cited 2020 Aug 13]. Available from: http:\/\/www.kansensho.or.jp\/modules\/en\/index.php?content_id=3."},{"key":"14","unstructured":"14. Wong EH, Porter JD, Edwards MR, Johnston SL. The role of macrolides in asthma: current evidence and future directions. Lancet Respir Med 2: 657-670, 2014."},{"key":"15","unstructured":"15. Clinical management of severe acute respiratory infection when novel coronavirus infection is suspected [Internet]. [cited 2020 Jun 2]. Available from: www.who.int\/publications-detail\/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Simonis FD, Iudibus G, Cremer OL, et al. Macrolide therapy is associated with reduced mortality in acute respiratory distress syndrome (ARDS) patients. Ann Transl Med 6: 24, 2018.","DOI":"10.21037\/atm.2017.12.25"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Brodie D, Bacchetta M. Extracorporeal membrane oxygen- ation for ARDS in adults. N Engl J Med 365: 1905-1914, 2011.","DOI":"10.1056\/NEJMct1103720"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. The Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 302: 1888-1895, 2009.","DOI":"10.1001\/jama.2009.1535"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A (H1N1). JAMA 306: 1659-1668, 2011.","DOI":"10.1001\/jama.2011.1471"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374: 1351-1363, 2009.","DOI":"10.1016\/S0140-6736(09)61069-2"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Alshahrani MS, Sindi A, Alshamsi F, et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care 8: 3, 2018.","DOI":"10.1186\/s13613-017-0350-x"},{"key":"22","unstructured":"22. Yang X, Yu Y, Shu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8: 475-481, 2020."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Zhang G, Hu C, Luo L, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol 127: 104364, 2020.","DOI":"10.1016\/j.jcv.2020.104364"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/1\/60_5475-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T03:47:11Z","timestamp":1609559231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/1\/60_5475-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5475-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}